Skip to main content

Advertisement

Log in

Central serous chorioretinopathy due to tadalafil use

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Phosphodiesterase-5 (PDE5) inhibitors are commonly used in the treatment of erectile dysfunction. There are a small number of case reports that associate this agent with central serous chorioretinopathy (CSCR). Our report presents the treatment approach to a 42-year-old patient who described blurred vision and metamorphopsia and was diagnosed with CSCR following the use of tadalafil, a PDE5 inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Central serous chorioretinopathy case-control study group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111:244–249

    Article  PubMed  Google Scholar 

  2. Scheider A, Nasemann JE, Lund OE (1993) Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser opthalmoscopy. Am J Ophthalmol 115:50–65

    PubMed  CAS  Google Scholar 

  3. Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121:26–34

    PubMed  CAS  Google Scholar 

  4. Iida T, Kishi S, Hagimura N, Shimizu K (1999) Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 19:508–512

    Article  PubMed  CAS  Google Scholar 

  5. Melman A, Gingell JC (1999) The epidemiology and pathophysiology of erectile dysfunction. J Urol 161:5–11

    Article  PubMed  CAS  Google Scholar 

  6. Lue TF (1990) Impotence: a patient goal directed approach to treatment. World J Urol 8:67–74

    Article  Google Scholar 

  7. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction sildenafil study group. N Engl J Med 338:1397–1404

    Article  PubMed  CAS  Google Scholar 

  8. Lugnier C (2006) Cylic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366–398

    Article  PubMed  CAS  Google Scholar 

  9. Laties AM, Zrenner E (2002) Viagra (sildenafil citrate) and ophthalmology. Prog Retin Eye Res 21:485–500

    Article  PubMed  CAS  Google Scholar 

  10. Carter JE (2007) Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause and coincidence? J Neurol Sci 262:89–97

    Article  PubMed  CAS  Google Scholar 

  11. Foresta C, Caretta N, Zuccarello D, Poletti A, Biagioli A, Caretti L (2008) Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects. Eye 22:144–149

    Article  PubMed  CAS  Google Scholar 

  12. Quiram P, Dumars S, Parwar B, Sarraf D (2005) Viagra-associated serous macular detachment. Graefes Arch Clin Exp Ophthalmol 243:339–344

    Article  PubMed  Google Scholar 

  13. French DD, Margo CE (2010) Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study. Retina 30:271–274

    Article  PubMed  Google Scholar 

  14. Aliferis K, Petropoulos IK, Farpour B, Matter MA, Safran AB (2012) Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors? Ophthalmologica 227:85–89

    Article  PubMed  CAS  Google Scholar 

  15. Gordon-Bennett P, Rimmer T (2012) Central serous chorioretinopathy following oral tadalafil. Eye 26:168–169

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fatih Mehmet Türkcü.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Türkcü, F.M., Yüksel, H., Şahin, A. et al. Central serous chorioretinopathy due to tadalafil use. Int Ophthalmol 33, 177–180 (2013). https://doi.org/10.1007/s10792-012-9646-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9646-x

Keywords

Navigation